NEK5 interacts with topoisomerase IIβ and is involved in the DNA damage response induced by etoposide

J Cell Biochem. 2019 Oct;120(10):16853-16866. doi: 10.1002/jcb.28943. Epub 2019 May 15.

Abstract

Cells are daily submitted to high levels of DNA lesions that trigger complex pathways and cellular responses by cell cycle arrest, apoptosis, alterations in transcriptional response, and the onset of DNA repair. Members of the NIMA-related kinase (NEK) family have been related to DNA damage response and repair and the first insight about NEK5 in this context is related to its role in centrosome separation resulting in defects in chromosome integrity. Here we investigate the potential correlation between NEK5 and the DNA damage repair index. The effect of NEK5 in double-strand breaks caused by etoposide was accessed by alkaline comet assay and revealed that NEK5-silenced cells are more sensitive to etoposide treatment. Topoisomerase IIβ (TOPIIβ) is a target of etoposide that leads to the production of DNA breaks. We demonstrate that NEK5 interacts with TOPIIβ, and the dynamics of this interaction is evaluated by proximity ligation assay. The complex NEK5/TOPIIβ is formed immediately after etoposide treatment. Taken together, the results of our study reveal that NEK5 depletion increases DNA damage and impairs proper DNA damage response, pointing out NEK5 as a potential kinase contributor to genomic stability.

Keywords: DNA damage response; NIMA-related kinase-5; comet assay; etoposide; proximity ligation assay; topoisomerase IIβ.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Apoptosis / drug effects
  • Cell Cycle Checkpoints / drug effects
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • DNA / drug effects
  • DNA / genetics
  • DNA Damage / genetics*
  • DNA Repair / genetics*
  • DNA Topoisomerases, Type II / metabolism*
  • Etoposide / pharmacology*
  • HEK293 Cells
  • Humans
  • NIMA-Related Kinases / genetics
  • NIMA-Related Kinases / metabolism*
  • Poly-ADP-Ribose Binding Proteins / metabolism*
  • RNA Interference
  • RNA, Small Interfering / genetics
  • Topoisomerase II Inhibitors / pharmacology*

Substances

  • Antineoplastic Agents
  • Poly-ADP-Ribose Binding Proteins
  • RNA, Small Interfering
  • Topoisomerase II Inhibitors
  • Etoposide
  • DNA
  • NIMA-Related Kinases
  • Nek5 protein, human
  • DNA Topoisomerases, Type II
  • TOP2B protein, human